CDSCO panel likely to take decision on Wednesday on granting market authorisation to SII's COVID-19 vaccine Covovax as heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin: Official sources— Press Trust of India (@PTI_News) January 10, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


